Literature DB >> 22318016

Enbrel patent surfaces.

Charlotte Harrison.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22318016     DOI： 10.1038/nbt0212-123

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  2 in total

1.  Switching to less expensive blindness drug could save medicare part B $18 billion over a ten-year period.

Authors:  David Hutton; Paula Anne Newman-Casey; Mrinalini Tavag; David Zacks; Joshua Stein
Journal:  Health Aff (Millwood)       Date:  2014-06       Impact factor: 6.301

Review 2.  Etanercept biosimilars.

Authors:  Valderilio F Azevedo; Nathalia Galli; Alais Kleinfelder; Julia D'Ippolito; Paulo C M Urbano
Journal:  Rheumatol Int       Date:  2014-07-01       Impact factor: 2.631
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.